It has been reported that RSPO2 regulates hepatocellular carcinoma (56), colon cancer progression (57), osteoblast activity (58), facial morphogenesis (59), and maturation of ovarian follicles (60) by activating canonical WNT/β-catenin signaling. The gene discussed is RSPO2; the disease is malignant colon neoplasm.